Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Research article

High frequency of Taenia solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of Mosango, Democratic Republic of Congo

Authors: Deby Mukendi, Jean-Roger Lilo Kalo, Pascal Lutumba, Barbara Barbé, Jan Jacobs, Cedric P. Yansouni, Sarah Gabriël, Pierre Dorny, François Chappuis, Marleen Boelaert, Andrea S. Winkler, Kristien Verdonck, Emmanuel Bottieau

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

The epidemiology of human cysticercosis and neurocysticercosis, caused by the larval stage of the pork tapeworm Taenia solium, is not well known in the Democratic Republic of Congo (DRC). Within a multicenter etiological and diagnostic study conducted by the NIDIAG consortium (“Better Diagnosis for Neglected Infections”) and investigating several challenging syndromes, we consecutively evaluated from 2012 to 2015 all patients older than 5 years presenting with neurological disorders (neurology cohort) and with fever > 7 days (persistent fever cohort) at the rural hospital of Mosango, province of Kwilu, DRC. In both cohorts, etiological diagnosis relied on a systematic set of reference laboratory assays and on pre-established clinical case definitions. No neuroimaging was available in the study hospital. In this study, we determined the frequency of T. solium infection in both cohorts and explored in the neurology cohort its association with specific neurological presentations and final etiological diagnoses.

Methods

We conducted a post-hoc descriptive and analytic study on cysticercosis in the neurology and persistent fever cohorts, based on the presence in serum samples of circulating T. solium antigen using the B158/B60 enzyme-linked immunosorbent assay (ELISA) and of cysticercosis IgG using the LDBIO Cysticercosis Western Blot IgG assay.

Results

For the neurology cohort, 340 samples (of 351 enrolled patients) were available for analysis (males: 46.8%; mean age: 38.9 years). T. solium antigen positivity was found in 43 participants (12.6%; 95% confidence interval [CI] 9.3–16.7%), including 9 of 60 (15%) patients with epilepsy. Among the 148 samples available from the persistent fever cohort (males: 39.9%; mean age: 19.9 years), 7 were positive in the T. solium antigen ELISA (4.7%; 95% CI 1.9–9.5%; P = 0.009 when compared to the neurology cohort). No significant association was found within the neurology cohort between positivity and clinical presentation or final diagnoses. Of note, the IgG antibody-detecting assay was found positive in only four (1.3%) of the participants of the neurology cohort and in none of the persistent fever cohort.

Conclusions

T. solium antigen positivity was found in at least 10% of patients admitted with neurological disorders in the Kwilu province, DRC, with no specific pattern of presentation. Further neuroimaging studies should be used to confirm whether neurocysticercosis is prevalent in this region.
Literature
4.
go back to reference Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011;5(5):e1152.CrossRef Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011;5(5):e1152.CrossRef
5.
go back to reference Wallin MT, Pretell EJ, Bustos JA, Caballero M, Alfaro M, Kane R, et al. Cognitive changes and quality of life in neurocysticercosis: a longitudinal study. PLoS Negl Trop Dis. 2012;6(1):e1493.CrossRef Wallin MT, Pretell EJ, Bustos JA, Caballero M, Alfaro M, Kane R, et al. Cognitive changes and quality of life in neurocysticercosis: a longitudinal study. PLoS Negl Trop Dis. 2012;6(1):e1493.CrossRef
10.
go back to reference Gabriël S, Blocher J, Dorny P, Abatih EN, Schmutzhard E, Ombay M, et al. Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings. PLoS Negl Trop Dis. 2012;6(10):1–8.CrossRef Gabriël S, Blocher J, Dorny P, Abatih EN, Schmutzhard E, Ombay M, et al. Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings. PLoS Negl Trop Dis. 2012;6(10):1–8.CrossRef
14.
go back to reference Yansouni CP, Bottieau E, Lutumba P, Winkler AS, Yansouni CP, Bottieau E, et al. Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis. 2013;13:546–58.CrossRef Yansouni CP, Bottieau E, Lutumba P, Winkler AS, Yansouni CP, Bottieau E, et al. Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis. 2013;13:546–58.CrossRef
18.
go back to reference Praet N, Kanobana K, Kabwe C, Maketa V, Lukanu P, Lutumba P, et al. Taenia solium cysticercosis in the democratic Republic of Congo: how does pork trade affect the transmission of the parasite? PLoS Negl Trop Dis. 2010;4(9):e817.CrossRef Praet N, Kanobana K, Kabwe C, Maketa V, Lukanu P, Lutumba P, et al. Taenia solium cysticercosis in the democratic Republic of Congo: how does pork trade affect the transmission of the parasite? PLoS Negl Trop Dis. 2010;4(9):e817.CrossRef
20.
go back to reference Boelaert M, Mukendi D, Bottieau E, Kalo Lilo JR, Verdonck K, Minikulu L, et al. A phase III diagnostic accuracy study of a rapid diagnostic test for diagnosis of second-stage human African trypanosomiasis in the Democratic Republic of the Congo. EBioMedicine. 2017;27:11–7.CrossRef Boelaert M, Mukendi D, Bottieau E, Kalo Lilo JR, Verdonck K, Minikulu L, et al. A phase III diagnostic accuracy study of a rapid diagnostic test for diagnosis of second-stage human African trypanosomiasis in the Democratic Republic of the Congo. EBioMedicine. 2017;27:11–7.CrossRef
22.
go back to reference Bottieau E, Mukendi D, Kalo J-RL, Lutumba P, Barbé B, Ramadan K, et al. Potential usefulness of C-reactive protein and procalcitonin determination in patients admitted for neurological disorders in rural Democratic Republic of Congo. Sci Rep. 2019;9(1):1–9.CrossRef Bottieau E, Mukendi D, Kalo J-RL, Lutumba P, Barbé B, Ramadan K, et al. Potential usefulness of C-reactive protein and procalcitonin determination in patients admitted for neurological disorders in rural Democratic Republic of Congo. Sci Rep. 2019;9(1):1–9.CrossRef
23.
go back to reference Garcia HH, O’Neal SE, Noh J, Handali S, Gilman RH, Gonzalez AE, et al. Laboratory diagnosis of Neurocysticercosis (Taenia solium). J Clin Microbiol. 2018;56(9):e00424–18.CrossRef Garcia HH, O’Neal SE, Noh J, Handali S, Gilman RH, Gonzalez AE, et al. Laboratory diagnosis of Neurocysticercosis (Taenia solium). J Clin Microbiol. 2018;56(9):e00424–18.CrossRef
24.
go back to reference Blocher J, Schmutzhard E, Wilkins PP, Gupton PN, Schaffert M, Auer H, et al. A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches. PLoS Negl Trop Dis. 2011;5(6):e1185.CrossRef Blocher J, Schmutzhard E, Wilkins PP, Gupton PN, Schaffert M, Auer H, et al. A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches. PLoS Negl Trop Dis. 2011;5(6):e1185.CrossRef
27.
go back to reference Fleury A. Development of point-of-care tests for Taenia solium: one of the ways to obtain a better diagnosis and therapeutic management of patients, and to reach eradication. Pathog Glob Health. 2019;113:323–4 Taylor and Francis Ltd.CrossRef Fleury A. Development of point-of-care tests for Taenia solium: one of the ways to obtain a better diagnosis and therapeutic management of patients, and to reach eradication. Pathog Glob Health. 2019;113:323–4 Taylor and Francis Ltd.CrossRef
31.
go back to reference Mwanjali G, Kihamia C, Kakoko DVC, Lekule F, Ngowi H, Johansen MV, et al. Prevalence and risk factors associated with human taenia solium infections in Mbozi District, Mbeya Region, Tanzania. PLoS Negl Trop Dis. 2013;7(3):e2102.CrossRef Mwanjali G, Kihamia C, Kakoko DVC, Lekule F, Ngowi H, Johansen MV, et al. Prevalence and risk factors associated with human taenia solium infections in Mbozi District, Mbeya Region, Tanzania. PLoS Negl Trop Dis. 2013;7(3):e2102.CrossRef
32.
go back to reference Musoke A, Dorny P, Kabwe C, Kirezi K, Lukanu K, Lutumba P, et al. Cysticercosis in the Democratic Republic of Congo. Onderstepoort J Vet Res. 2012;79:1 AOSIS (pty) Ltd.CrossRef Musoke A, Dorny P, Kabwe C, Kirezi K, Lukanu K, Lutumba P, et al. Cysticercosis in the Democratic Republic of Congo. Onderstepoort J Vet Res. 2012;79:1 AOSIS (pty) Ltd.CrossRef
33.
go back to reference Willingham AL 3rd, De NV, Doanh NQ, Cong le D, Dung TV, Dorny P, et al. Current status of cysticercosis in Vietnam. Southeast Asian J Trop Med Public Heal. 2003;34(Suppl 1):35–50. Willingham AL 3rd, De NV, Doanh NQ, Cong le D, Dung TV, Dorny P, et al. Current status of cysticercosis in Vietnam. Southeast Asian J Trop Med Public Heal. 2003;34(Suppl 1):35–50.
34.
go back to reference Coral-Almeida M, Gabriël S, Abatih EN, Praet N, Benitez W, Dorny P. Taenia solium human cysticercosis: a systematic review of sero-epidemological data from endemic zones around the world. PLoS Negl Trop Dis. 2015;9(7):e0003919.CrossRef Coral-Almeida M, Gabriël S, Abatih EN, Praet N, Benitez W, Dorny P. Taenia solium human cysticercosis: a systematic review of sero-epidemological data from endemic zones around the world. PLoS Negl Trop Dis. 2015;9(7):e0003919.CrossRef
35.
go back to reference Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010;4(11):e870.CrossRef Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010;4(11):e870.CrossRef
36.
go back to reference Bruno E, Bartoloni A, Zammarchi L, Strohmeyer M, Bartalesi F, Bustos J, et al. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7(10):e2480.CrossRef Bruno E, Bartoloni A, Zammarchi L, Strohmeyer M, Bartalesi F, Bustos J, et al. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7(10):e2480.CrossRef
Metadata
Title
High frequency of Taenia solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of Mosango, Democratic Republic of Congo
Authors
Deby Mukendi
Jean-Roger Lilo Kalo
Pascal Lutumba
Barbara Barbé
Jan Jacobs
Cedric P. Yansouni
Sarah Gabriël
Pierre Dorny
François Chappuis
Marleen Boelaert
Andrea S. Winkler
Kristien Verdonck
Emmanuel Bottieau
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06032-8

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.